Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gustavsson

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
Journal of Chromatography. B, Biomedical Sciences and Applications|November 26, 1999
Rapid method for relative gene expression determination in human tissues using automated capillary gel electrophoresis and multicolor detectionE Odin, Y Wettergren, L Larsson, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 1, 1976
Inactivation of 5-fluorouracil by the liver during continuous regional and systemic infusion in pigsO Almersjö, A Brandberg, B Gustavsson, et al.
International Journal of Cancer|April 17, 2001
Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)C Borgfeldt, S R Hansson, B Gustavsson, et al.
Acta Chirurgica Scandinavica|January 1, 1984
Effects of hydralazine on liver blood flow in normovolemic dogsT Saretok, O Almersjö, B Biber, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Different intravenous administration techniques for 5-fluorouracil. Pharmacokinetics and pharmacodynamic effectsP A Larsson, G Carlsson, B Gustavsson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1995
Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptorB Casslén, J Nordengren, B Gustavsson, et al.
Scanning Electron Microscopy|January 1, 1986
Surface morphology of unused and used Hydromer-coated intravenous cathetersA Bylock, E Hultman, B Gustavsson, et al.
Molecular and Cellular Endocrinology|June 1, 1995
Functional analysis of a variant of the thyrotropin receptor gene in a family with Graves' diseaseB Gustavsson, C Eklöf, K Westermark, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2005
Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancerM Oman, S Lundqvist, B Gustavsson, et al.
Lakartidningen|December 13, 1995
[Possible effect of administration methods on pharmacological action. Study of cytostatic therapy in advanced cancer]P A Larsson, G Carlsson, B Gustavsson, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
Journal of Chromatography. B, Biomedical Sciences and Applications|November 26, 1999
Rapid method for relative gene expression determination in human tissues using automated capillary gel electrophoresis and multicolor detectionE Odin, Y Wettergren, L Larsson, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 1, 1976
Inactivation of 5-fluorouracil by the liver during continuous regional and systemic infusion in pigsO Almersjö, A Brandberg, B Gustavsson, et al.
International Journal of Cancer|April 17, 2001
Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)C Borgfeldt, S R Hansson, B Gustavsson, et al.
Acta Chirurgica Scandinavica|January 1, 1984
Effects of hydralazine on liver blood flow in normovolemic dogsT Saretok, O Almersjö, B Biber, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Different intravenous administration techniques for 5-fluorouracil. Pharmacokinetics and pharmacodynamic effectsP A Larsson, G Carlsson, B Gustavsson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1995
Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptorB Casslén, J Nordengren, B Gustavsson, et al.
Scanning Electron Microscopy|January 1, 1986
Surface morphology of unused and used Hydromer-coated intravenous cathetersA Bylock, E Hultman, B Gustavsson, et al.
Molecular and Cellular Endocrinology|June 1, 1995
Functional analysis of a variant of the thyrotropin receptor gene in a family with Graves' diseaseB Gustavsson, C Eklöf, K Westermark, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2005
Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancerM Oman, S Lundqvist, B Gustavsson, et al.
Lakartidningen|December 13, 1995
[Possible effect of administration methods on pharmacological action. Study of cytostatic therapy in advanced cancer]P A Larsson, G Carlsson, B Gustavsson, et al.
Pageof 13